BIOL logo

BIOLASE (BIOL) Accounts Payable

Annual Accounts Payable

$6.07 M
+$279.00 K+4.82%

December 31, 2023

Summary

Performance

1-Year Change

+4.82%

3-Year Change

+128.78%

5-Year Change

+1.88%

15-Year Change

+18.71%

BIOL Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$9.13 M
BIOL annual accounts payable is currently -33.53% below its historical high of $9.13 million

3-Year Low

$3.31 M
BIOL annual accounts payable is currently +83.29% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
BIOL previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
BIOL next annual earnings announcement has not yet been scheduled

OtherBIOLbalance sheetmetrics:

Annual Accounts Receivable

$5.48 M
BIOL annual accounts receivable is $5.48 million

Annual Total Liabilities

$35.35 M
BIOL annual total liabilities is $35.35 million

Annual Total Assets

$35.10 M
BIOL annual total assets is $35.10 million

Annual Current Assets

$24.86 M
BIOL annual total current assets is $24.86 million

Quarterly Accounts Payable

$3.00 M
-$2.49 M-45.35%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

-58.19%

3-Year Change

-58.19%

5-Year Change

-58.19%

BIOL Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$10.02 M
BIOL quarterly accounts payable is currently -70.04% below its historical high of $10.02 million

3-Year Low

$3.00 M
BIOL quarterly accounts payable is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BIOL previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
BIOL next earnings announcement has not yet been scheduled

OtherBIOLbalance sheetmetrics:

Quarterly Accounts Receivable

$3.53 M
BIOL quarterly accounts receivable is $3.53 million

Quarterly Total Liabilities

$32.47 M
BIOL quarterly total liabilities is $32.47 million

Quarterly Total Assets

$27.24 M
BIOL quarterly total assets is $27.24 million

Quarterly Current Assets

$19.43 M
BIOL quarterly total current assets is $19.43 million

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

BIOL Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+4.8%-58.2%
3 y3 years+128.8%-58.2%
5 y5 years+1.9%-58.2%

BIOL Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high-45.4%-60.2%at low
5 y5-yearat high-56.3%-60.2%-16.4%
alltimeall time-33.5%-98.4%-70.0%-96.7%

BIOLASE Accounts Payable History

DateAnnualQuarterly
Sep 2024
-
$3.00 M(-45.3%)
Jun 2024
-
$5.49 M(+11.7%)
Mar 2024
-
$4.92 M(-19.0%)
Dec 2023
$6.07 M(+4.8%)
$6.07 M(-15.5%)
Sep 2023
-
$7.18 M(+13.7%)
Jun 2023
-
$6.31 M(-16.3%)
Mar 2023
-
$7.54 M(+30.3%)
Dec 2022
$5.79 M(+74.9%)
$5.79 M(+16.3%)
Sep 2022
-
$4.97 M(+0.3%)
Jun 2022
-
$4.96 M(+6.8%)
Mar 2022
-
$4.64 M(+40.3%)
Dec 2021
$3.31 M(+24.8%)
$3.31 M(-8.0%)
Sep 2021
-
$3.60 M(+2.7%)
Jun 2021
-
$3.50 M(+14.0%)
Mar 2021
-
$3.07 M(+15.9%)
Dec 2020
$2.65 M(-50.3%)
$2.65 M(+2.3%)
Sep 2020
-
$2.59 M(+3.3%)
Jun 2020
-
$2.51 M(-38.1%)
Mar 2020
-
$4.06 M(-23.9%)
Dec 2019
$5.33 M(-10.4%)
$5.33 M(-19.3%)
Sep 2019
-
$6.60 M(+12.4%)
Jun 2019
-
$5.88 M(-0.3%)
Mar 2019
-
$5.89 M(-1.0%)
Dec 2018
$5.95 M(+16.5%)
$5.95 M(-21.4%)
Sep 2018
-
$7.57 M(+9.2%)
Jun 2018
-
$6.93 M(+19.8%)
Mar 2018
-
$5.79 M(+13.2%)
Dec 2017
$5.11 M(-44.0%)
$5.11 M(-33.5%)
Sep 2017
-
$7.68 M(-6.0%)
Jun 2017
-
$8.17 M(-11.1%)
Mar 2017
-
$9.18 M(+0.6%)
Dec 2016
$9.13 M(+53.1%)
$9.13 M(+15.9%)
Sep 2016
-
$7.88 M(+13.9%)
Jun 2016
-
$6.91 M(-0.8%)
Mar 2016
-
$6.97 M(+17.0%)
Dec 2015
$5.96 M(-28.7%)
$5.96 M(-36.0%)
Sep 2015
-
$9.31 M(+5.2%)
Jun 2015
-
$8.85 M(+15.7%)
Mar 2015
-
$7.64 M(-8.5%)
Dec 2014
$8.36 M(-2.4%)
$8.36 M(-12.4%)
Sep 2014
-
$9.54 M(-4.8%)
Jun 2014
-
$10.02 M(+28.8%)
Mar 2014
-
$7.78 M(-9.2%)
Dec 2013
$8.56 M(+11.7%)
$8.56 M(-8.4%)
Sep 2013
-
$9.35 M(+0.5%)
Jun 2013
-
$9.30 M(+6.8%)
Mar 2013
-
$8.71 M(+13.6%)
Dec 2012
$7.66 M(-1.8%)
$7.66 M(+6.7%)
Sep 2012
-
$7.18 M(+4.7%)
Jun 2012
-
$6.86 M(-8.8%)
Mar 2012
-
$7.52 M(-3.6%)
Dec 2011
$7.80 M(+93.7%)
$7.80 M(+33.2%)
Sep 2011
-
$5.86 M(+16.4%)
Jun 2011
-
$5.04 M(+10.9%)
Mar 2011
-
$4.54 M(+12.7%)
Dec 2010
$4.03 M(-17.6%)
$4.03 M(-4.6%)
Sep 2010
-
$4.22 M(-6.0%)
Jun 2010
-
$4.49 M(+11.6%)
Mar 2010
-
$4.03 M(-17.6%)
Dec 2009
$4.89 M
$4.89 M(-7.5%)
Sep 2009
-
$5.28 M(+14.6%)
DateAnnualQuarterly
Jun 2009
-
$4.61 M(+8.1%)
Mar 2009
-
$4.26 M(-43.2%)
Dec 2008
$7.51 M(+22.1%)
$7.51 M(-9.6%)
Sep 2008
-
$8.30 M(+15.2%)
Jun 2008
-
$7.21 M(-9.2%)
Mar 2008
-
$7.93 M(+29.0%)
Dec 2007
$6.15 M(-20.1%)
$6.15 M(-9.6%)
Sep 2007
-
$6.81 M(+22.5%)
Jun 2007
-
$5.56 M(-23.9%)
Mar 2007
-
$7.31 M(-5.1%)
Dec 2006
$7.70 M(-0.8%)
$7.70 M(+22.4%)
Sep 2006
-
$6.29 M(-6.6%)
Jun 2006
-
$6.74 M(-30.6%)
Mar 2006
-
$9.70 M(+25.0%)
Dec 2005
$7.76 M(+8.6%)
$7.76 M(+12.4%)
Sep 2005
-
$6.90 M(-16.4%)
Jun 2005
-
$8.26 M(+7.5%)
Mar 2005
-
$7.68 M(+7.4%)
Dec 2004
$7.15 M(+88.3%)
$7.15 M(+60.6%)
Sep 2004
-
$4.45 M(+22.3%)
Jun 2004
-
$3.64 M(+79.7%)
Mar 2004
-
$2.02 M(-46.7%)
Dec 2003
$3.80 M(+82.3%)
$3.80 M(+55.3%)
Sep 2003
-
$2.44 M(+30.1%)
Jun 2003
-
$1.88 M(+12.6%)
Mar 2003
-
$1.67 M(-19.8%)
Dec 2002
$2.08 M(+25.7%)
$2.08 M(+55.6%)
Sep 2002
-
$1.34 M(-5.9%)
Jun 2002
-
$1.42 M(-18.3%)
Mar 2002
-
$1.74 M(+5.1%)
Dec 2001
$1.66 M(+75.1%)
$1.66 M(+34.0%)
Sep 2001
-
$1.24 M(+23.3%)
Jun 2001
-
$1.00 M(+27.5%)
Mar 2001
-
$785.90 K(-16.9%)
Dec 2000
$946.00 K(+19.4%)
$946.00 K(+13.0%)
Sep 2000
-
$837.30 K(+33.9%)
Jun 2000
-
$625.20 K(-36.0%)
Mar 2000
-
$977.10 K(+23.4%)
Dec 1999
$792.10 K(-1.0%)
$792.10 K(+58.4%)
Sep 1999
-
$500.00 K(-28.6%)
Jun 1999
-
$700.00 K(-22.2%)
Mar 1999
-
$900.00 K(+12.5%)
Dec 1998
$800.00 K(+60.0%)
$800.00 K(+100.0%)
Sep 1998
-
$400.00 K(+100.0%)
Jun 1998
-
$200.00 K(0.0%)
Mar 1998
-
$200.00 K(-60.0%)
Dec 1997
$500.00 K(+400.0%)
$500.00 K(+66.7%)
Sep 1997
-
$300.00 K(+200.0%)
Jun 1997
-
$100.00 K(-50.0%)
Mar 1997
-
$200.00 K(+100.0%)
Dec 1996
$100.00 K(0.0%)
$100.00 K(0.0%)
Sep 1996
-
$100.00 K(0.0%)
Jun 1996
-
$100.00 K(0.0%)
Mar 1995
-
$100.00 K(0.0%)
Dec 1994
$100.00 K(-66.7%)
$100.00 K(-66.7%)
Dec 1993
$300.00 K(-75.0%)
$300.00 K(-50.0%)
Sep 1993
-
$600.00 K(-50.0%)
Jun 1993
-
$1.20 M(+9.1%)
Mar 1993
-
$1.10 M(-8.3%)
Dec 1992
$1.20 M
$1.20 M(-29.4%)
Sep 1992
-
$1.70 M(+54.5%)
Jun 1992
-
$1.10 M

FAQ

  • What is BIOLASE annual accounts payable?
  • What is the all time high annual accounts payable for BIOLASE?
  • What is BIOLASE annual accounts payable year-on-year change?
  • What is BIOLASE quarterly accounts payable?
  • What is the all time high quarterly accounts payable for BIOLASE?
  • What is BIOLASE quarterly accounts payable year-on-year change?

What is BIOLASE annual accounts payable?

The current annual accounts payable of BIOL is $6.07 M

What is the all time high annual accounts payable for BIOLASE?

BIOLASE all-time high annual accounts payable is $9.13 M

What is BIOLASE annual accounts payable year-on-year change?

Over the past year, BIOL annual accounts payable has changed by +$279.00 K (+4.82%)

What is BIOLASE quarterly accounts payable?

The current quarterly accounts payable of BIOL is $3.00 M

What is the all time high quarterly accounts payable for BIOLASE?

BIOLASE all-time high quarterly accounts payable is $10.02 M

What is BIOLASE quarterly accounts payable year-on-year change?

Over the past year, BIOL quarterly accounts payable has changed by -$4.18 M (-58.19%)